Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12 USD | +3.45% | +2.52% | +127.85% |
07/05 | Canaccord Genuity Adjusts Price Target on Stoke Therapeutics to $20 From $21, Maintains Buy Rating | MT |
06/05 | Earnings Flash (STOK) STOKE THERAPEUTICS Reports Q1 Revenue $4.2M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+127.85% | 605M | |
+24.19% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.16% | 25.78B | |
-21.06% | 19.26B | |
+3.19% | 12.14B | |
-2.14% | 12.08B | |
+30.01% | 11.98B |
- Stock Market
- Equities
- STOK Stock
- News Stoke Therapeutics, Inc.
- Cantor Fitzgerald Adjusts Price Target for Stoke Therapeutics to $38 From $68, Retains Overweight Rating